🇺🇸 CYTK — Cytokinetics, Incorporated

Salud Compra fuerte
← Volver

Precio actual

55,55 USD

Máx. histórico

108,06

1032 días

Split 1:6 del 25/06/2013

Caída desde máximo

-48,59%

Rango 52 semanas

54,16 – 88,31

Variación hoy

-12,66%

Cierre anterior

63,60

Rango de hoy

54,16 – 60,84

Volumen hoy

6.774.495

Peor caída histórica

-97,06%

05/05/2004 → 10/10/2014

Recuperado en 3377 días

Volatilidad anualizada ⓘ

69,41%

Información
Nombre completo
Cytokinetics, Incorporated
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
673
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,39 USD (puede no estar actualizado)
Primera cotización
30/04/2004
Precio actualizado
hace 12 horas
Sobre la empresa

Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.

Splits Registrados en el histórico de precios
Fecha Ratio
25/06/2013 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/11/2020 17,49 17,94 16,00 16,52 -5,06% 11,09% 2.118.100
12/11/2020 17,15 17,70 16,70 17,40 +2,23% 5,83% 1.249.000
11/11/2020 17,11 17,18 16,47 17,02 +0,71% 4,15% 859.200
10/11/2020 16,90 17,23 16,02 16,90 +0,24% 7,16% 1.077.800
09/11/2020 17,43 17,84 16,45 16,86 -0,47% 7,97% 1.270.000
06/11/2020 17,55 17,55 16,67 16,94 -3,59% 5,01% 880.700
05/11/2020 18,01 18,39 17,22 17,57 -2,39% 6,50% 1.450.700
04/11/2020 16,62 18,30 16,62 18,00 +7,66% 10,11% 971.000
03/11/2020 16,00 16,92 15,81 16,72 +4,83% 6,94% 858.500
02/11/2020 15,48 16,00 15,17 15,95 +3,77% 5,36% 842.200
30/10/2020 15,44 15,46 14,91 15,37 -0,77% 3,56% 712.400
29/10/2020 15,41 15,75 14,89 15,49 +0,91% 5,58% 900.500
28/10/2020 15,75 16,05 15,26 15,35 -6,00% 5,02% 788.200
27/10/2020 15,66 16,49 15,41 16,33 +5,35% 6,90% 690.500
26/10/2020 16,22 16,58 15,35 15,50 -5,43% 7,58% 904.400
23/10/2020 16,20 16,54 15,90 16,39 +1,05% 3,95% 694.700
22/10/2020 15,75 16,63 15,74 16,22 +3,31% 5,65% 1.427.400
21/10/2020 16,15 16,59 15,52 15,70 -3,44% 6,63% 724.700
20/10/2020 16,60 17,20 16,20 16,26 -1,81% 6,02% 775.100
19/10/2020 16,55 16,99 16,45 16,56 +0,55% 3,26% 770.500
16/10/2020 16,25 17,15 16,21 16,47 +1,48% 5,78% 2.035.100
15/10/2020 16,35 16,70 15,85 16,23 -1,58% 5,20% 937.500
14/10/2020 16,90 17,58 16,33 16,49 -2,37% 7,40% 1.706.700
13/10/2020 15,64 17,06 15,58 16,89 +7,92% 9,46% 2.867.900
12/10/2020 15,12 15,98 14,71 15,65 +2,56% 8,40% 3.980.600
09/10/2020 16,12 16,50 15,01 15,26 -4,63% 9,24% 7.936.300
08/10/2020 17,45 17,73 15,16 16,00 -42,15% 14,73% 21.073.200
07/10/2020 28,54 29,55 27,61 27,66 -3,12% 6,80% 2.534.200
06/10/2020 29,04 29,25 27,83 28,55 -0,21% 4,89% 1.594.900
05/10/2020 26,33 30,14 26,26 28,61 +19,26% 14,74% 3.930.500